Analysts at CJS Securities downgraded shares of Haemonetics Corp. (NYSE: HAE) from Outperform to Market Perform in a research note to investors today. With a rating of Market Perform on the shares, Haemonetics Corp. has a 52-week high of $38.06. …

Shares of Haemonetics Corp. (NYSE: HAE) were downgraded by analysts at CJS Securities in a note to their investors today. The company currently has a rating of Market Perform on the stock. The one-year price target of $35.00 is lower …